SonoCare Lab secures seed funding from Bluepoint Partners for ultrasound brain waste removal device

SonoCare Lab, a startup developing ultrasound-based medical devices for brain diseases, has secured seed investment from the deep tech accelerator Bluepoint Partners. The company aims to create a companion device for Alzheimer's antibody treatments that assists in the removal of metabolic waste from the brain. The specific investment amount and company valuation were not disclosed.

The startup was founded by Professor Jinhyung Park of Sungkyunkwan University, who developed the core ultrasound technology while working on a Samsung Future Technology Cultivation Project. The company focuses on the glymphatic system, a mechanism involving the circulation of cerebrospinal fluid and interstitial fluid to clear metabolic waste from the brain. SonoCare Lab believes that addressing waste removal is necessary alongside the removal of pathological substances through medication.

The core technology is the Acoustic Brain Sweeper, which uses a proprietary sweeping technique to move ultrasound in a specific direction. This method stimulates the pathways for waste discharge to activate the brain's natural clearance functions. The company plans to develop this technology as a companion device to be used with Alzheimer's antibody therapies, aiming to enhance treatment efficiency by combining drug therapy with ultrasound assistance.

Professor Park, the company's representative, holds a doctorate in biomedical engineering from the University of Southern California and has experience in ultrasound system development at Siemens Korea and Philips. Bluepoint Partners' representative noted that the company possesses differentiated technology for non-invasively regulating brain waste mechanisms. The founder stated the goal is to enter the companion device market for antibody therapies and eventually grow into a platform for various central nervous system diseases. The company faces challenges in verifying clinical efficacy and obtaining medical device approvals.

Reported by StartupN.